Abstract
Human chorionic gonadotropin (HCG) is an important tumor marker in the diagnosis and monitoring of treatment response in childhood cancers such as germ cell tumors and liver tumors. The effect of chronic kidney disease (CKD) on increased HCG is not a well-researched issue. HCG elevation of unknown cause not only causes diagnostic confusion, but also causes economic loss by necessitating many unnecessary examinations.In the current report a boy with elevated HCG levels with chronic kidney disease is presented.
Keywords
References
- 1. Soni S, Menon MC, Bhaskaran M, Jhaveri KD, Molmenti E, Muoio V. Elevated human chorionic gonadotropin levels in patients with chronic kidney disease: Case series and review of literature. Indian J Nephrol. 2013;23:424-427.
- 2. Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: Clinical features, prognostic implications and therapeutic options. J Nephrol. 2012;25:31–42.
- 3. Rani BS, Suchitra MM, Srinivasa Rao PVLN, Kumar VS. Serum tumor markers in advanced stages of chronic kidney diseases. Saudi J Kidney Dis Transpl. 2019;30:898-904.
Abstract
İnsan koryonik gonadotropin (HCG), germ hücreli tümörler ve karaciğer tümörleri gibi çocukluk çağı kanserlerinde tanı ve tedavi yanıtının izlenmesinde önemli bir tümör belirtecidir. Kronik böbrek hastalığının (KBH) artan HCG üzerindeki etkisi iyi araştırılmış bir konu değildir. Nedeni bilinmeyen HCG yüksekliği sadece tanı karmaşasına neden olmakla kalmaz, aynı zamanda birçok gereksiz tetkiki gerektirerek ekonomik kayıplara da neden olur.Bu raporda HCG düzeyi yüksek, kronik böbrek hastalığı olan bir erkek çocuk sunulmaktadır.
Keywords
References
- 1. Soni S, Menon MC, Bhaskaran M, Jhaveri KD, Molmenti E, Muoio V. Elevated human chorionic gonadotropin levels in patients with chronic kidney disease: Case series and review of literature. Indian J Nephrol. 2013;23:424-427.
- 2. Iglesias P, Carrero JJ, Díez JJ. Gonadal dysfunction in men with chronic kidney disease: Clinical features, prognostic implications and therapeutic options. J Nephrol. 2012;25:31–42.
- 3. Rani BS, Suchitra MM, Srinivasa Rao PVLN, Kumar VS. Serum tumor markers in advanced stages of chronic kidney diseases. Saudi J Kidney Dis Transpl. 2019;30:898-904.
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Letter to the Editor |
| Authors | |
| Publication Date | September 30, 2022 |
| Acceptance Date | July 24, 2022 |
| Published in Issue | Year 2022 Volume: 47 Issue: 3 |
